Biolase BIOL shares are trading higher on Wednesday after the company issued third-quarter sales guidance above analyst estimates.
Biolase is a US-based medical device company. It develops, manufactures, markets and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners.
Biolase shares traded up 3.39% to 33 cents on Wednesday. The stock has a 52-week high of $1.07 and a 52-week low of 21 cents.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in